European journal of radiology
-
Multicenter Study Clinical Trial
Response assessment of colorectal liver metastases with contrast enhanced CT/18F-FDG PET.
Evaluate the diagnostic performance of contrast enhanced CT/PET (ceCT/PET) in the response assessment of patients with colorectal cancer liver metastases. ⋯ Administration of intravenous contrast in the PET/CT is mandatory to evaluate treatment response rate of liver metastases due to the limitations of isolated metabolic images in these cases.